Influencer Fatigue and Deinfluencing Hashtags Show Gen Z’s Ability to Sniff Out Inauthentic Content

 

If you’re growing weary of the constant bombardment of paid content and sponsored posts on social media, chances are you’re not alone. Market research firm GWI found that Gen Z’s engagement with influencers has fallen by 12% since 2020. And now, terms like influencer fatigue and deinfluencing are growing in popularity as consumers share their discontent with an inundation of influencer marketing.

In fact, deinfluencing has become a viral trend on video sharing platform TikTok. With millions of hashtags, this trend actually involves internet users listing out the products they regret purchasing. Some influencers themselves have even jumped on the bandwagon. And while influencer critique has been around for a while, it really exploded to industry-wide prominence last month when a popular beauty influencer was accused of wearing fake lashes while advertising a L’Oréal mascara.

It’s clear consumers are growing tired of the current standard for influencer brand partnerships. But will influencer fatigue and deinfluencing have any ramifications on the influencer marketing economy, which is currently worth over $16 billion? Anna Sullivan, founder and CEO of The Creative Exchange, which helps brands create meaningful content for social media, dissects influencer fatigue and gives retailers a more constructive way of viewing the resistance to this marketing trend.

Anna’s Thoughts:

“You may have recently heard the term deinfluencing, which is now its own trend on TikTok. After the last few years, I think consumers are getting very tired of influencer marketing and them just promoting products with a full script. So, deinfluencing is where regular users are debunking the myth or the truths that these influencers are sharing about products, and even telling you other brands or products that you should be purchasing instead. So influencer marketing isn’t dead, but consumers are just so much more aware of what they should listen to versus try out on their own.”

Follow us on social media for the latest updates in B2B!

Image

Latest

AI in marketing
From Queries to Conversations with AI in Marketing Analytics
April 21, 2025

In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…

Read More
ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More